Breathe Well Live Well
|
Novel Molecular Target for Asthma and Cancer Identified
Genetic Engineering News Researchers at the Johns Hopkins Kimmel Cancer Center described an enzyme involved in T-cell regulation that could be a useful target in treating asthma and boosting the effects of certain cancer therapies. In a study (“The AGC kinase SGK1 regulates … |
View full post on asthma – Google News
Laboratory Equipment |
Salmonella Infections Reduce Asthma Attacks
Genetic Engineering News Scientists in Germany say they have pinpointed the mechanism by which Salmonella infections can reduce the incidence of asthma in mice. They point out that their research (“Salmonella Typhimurium Infection Induced CD11b+Gr1+ Cells Ameliorate Allergic … Salmonella Infection Mitigates Asthma |
View full post on asthma – Google News
|
Asthma Prescription Numbers Slow Down
Genetic Engineering News The asthma prescription market is slowing as the leading drugs lose patent protection. But leading market researchers BCC and GBI Research each predict moderate growth until at least 2017, thanks to new market entrants and a disease prevalence that … |
View full post on asthma – Google News
Drug Discovery & Development |
Cancer Research UK to Repurpose AstraZeneca Asthma Drug for Kidney Cancer
Genetic Engineering News AZD2098 was originally designed to treat asthma. CRUK says this deal with AZ will enable its Drug Development Office (DDO) to complete preclinical development and carry out early clinical trials of the compound to see if it can benefit kidney cancer … Cancer Research UK, AstraZeneca To Repurpose Asthma Drug for Kidney Cancer |
View full post on asthma – Google News
|
Phase III Success for Boehringer Ingelheim Asthma Drug
Genetic Engineering News Boehringer-Ingelheim said today its once-daily asthma drug tiotropium, delivered via Respimat® Soft Mist™ Inhaler, produced favorable Phase III results by increasing the time to first severe exacerbation, and time to first episode of asthma worsening … Boehringer Ingelheim's tiotropium shows promising results in patients with … Phase III results: tiotropium* Respimat® effective in symptomatic asthma … Boehringer Ingelheim reports positive data from symptomatic asthma trials |
View full post on asthma – Google News
|
Engineering Undergrads Create Game-Changing Asthma Management Device
Newswise (press release) Newswise — An estimated 300 million people in the world suffer from asthma. That number is expected to grow to more than 400 million by 2025. While diagnosis and treatment in the United States is accessible, people living in the developing world have … |
View full post on asthma – Google News
|
Asthma: Single Target, Double Blow
Genetic Engineering News A recently identified calcium activated chloride channel (CaCC) in the airway surface epithelium and airway smooth muscle (ASM) cells of asthma patients could represent a target for reducing the excess mucus production and ASM hyperresponsiveness that … |
View full post on asthma – Google News
|
Blocking Single Target Deals Asthma a Double Blow
Genetic Engineering News A recently identified calcium activated chloride channel (CaCC) in the airway surface epithelium and airway smooth muscle (ASM) cells of asthma patients could represent a target for reducing the excess mucus production and ASM hyperresponsiveness that … |
View full post on asthma – Google News
|
AstraZeneca, Rigel Sign Potentially $100M Asthma Drug Deal
Genetic Engineering News Drug firm will start first-in-man studies and carry out clinical development program for R256. |
View full post on asthma – Google News
|
GSK, Theravance Report Mixed-Bag of Data for Relovair in COPD, Asthma
Genetic Engineering News GlaxoSmithKline (GSK) and Theravance are reporting mostly positive results from two studies for Relovair in chronic obstructive pulmonary disease (COPD) and asthma. Relovair met its primary endpoint in one of two replicate studies in COPD comparing it … GSK and Theravance Announce Completion of the Relovair(TM)* Registrational … GSK lung drug has mixed results but filing on track GSK's Relovair on track for COPD drug filing; talks on asthma in US ongoing |
View full post on asthma – Google News